C07D 267/16
Condensed with two six-membered rings
Official title: condensed with two six-membered rings
C07D267/16 (Condensed with two six-membered rings) appears on 137 US grants and 91 published applications in this corpus.
Search patents in C07D- Granted patents
- 137
- Published applications
- 91
- Assignees
- 69
- Inventors
- 382
- Latest grant
- 9 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 2 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 3 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 4 | 0 |
| 1993 | 5 | 0 |
| 1994 | 8 | 0 |
| 1995 | 10 | 0 |
| 1996 | 5 | 0 |
| 1997 | 9 | 0 |
| 1998 | 15 | 0 |
| 1999 | 3 | 0 |
| 2000 | 3 | 0 |
| 2001 | 1 | 1 |
| 2002 | 2 | 3 |
| 2003 | 2 | 1 |
| 2004 | 0 | 1 |
| 2005 | 3 | 2 |
| 2006 | 1 | 7 |
| 2007 | 2 | 3 |
| 2008 | 1 | 5 |
| 2009 | 1 | 4 |
| 2010 | 0 | 4 |
| 2011 | 0 | 4 |
| 2012 | 4 | 3 |
| 2013 | 3 | 0 |
| 2014 | 2 | 5 |
| 2015 | 3 | 4 |
| 2016 | 0 | 2 |
| 2017 | 2 | 6 |
| 2018 | 2 | 5 |
| 2019 | 3 | 2 |
| 2020 | 3 | 4 |
| 2021 | 5 | 4 |
| 2022 | 1 | 2 |
| 2023 | 4 | 11 |
| 2024 | 1 | 3 |
| 2025 | 7 | 2 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Imaging histone deacetylases with a radiotracer using positron emission tomography9 Dec 2025US 12,491,270 B2The General Hospital Corporation
- Tricyclic compounds with OMA1/OPA1 modulatory properties11 Nov 2025US 12,466,819 B2712 North Inc.
- Ring closing synthesis of macrocyclic MCL-1 inhibitor intermediates14 Oct 2025US 12,441,741 B2Amgen Inc.
- c-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same7 Oct 2025US 12,435,047 B2Pontifica Universidad Catoclica de Chile
- Synthesis of vinylic protected alcohol intermediates7 Oct 2025US 12,435,049 B2Amgen Inc.
- Slack-activating compounds and their medical use3 Sep 2026US 2026/0258003 A1
- Treatment methods16 Apr 2026US 2026/0102407 A1
- Processes and intermediates for preparing mcl1 inhibitors26 Feb 2026US 2026/0055068 A1Gilead Sciences, Inc.
- C-abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same6 Nov 2025US 2025/0340521 A1Pontificia Universidad Catolica De Chile
- Mcl-1 inhibitors15 May 2025US 2025/0154116 A1Gilead Sciences, Inc.
Most cited
By later US patents
- Tricyclic ethers, their preparation and the pharmaceutical compositions containing them138US 4,496,557 AAdir · 1985
- Hexahydro-5-imino-1,4-1,4-thiazepine derivatives as inhibitors of nitric oxide synthases64US 6,372,733 B1Merck & Co., Inc. · 2002
- Tricyclic benzazepine vasopressin antagonists50US 5,512,563 AAmerican Cyanamid Company · 1996
- Tricyclic benzazepine vasopressin antagonists46US 5,849,735 AAmerican Cyanamid Company · 1998
- 8-chlorodibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid, 2-[(phenylsulfinyl-, and phenylsulfonyl)alkanoyl]hydrazides43US 4,704,386 AG. D. Searle & Co. · 1987